USA Refuses 3rd Dose BioNTech Vaccine to be Downgraded to Age 16

Seen as one of the strongest outlets of the pandemic vaccineshas been on the agenda recently with the protection rates they provide against the virus and different variants of the virus. In this context, it is the most widely used vaccine in the media and in our country. BioNTech vaccine appears. The vaccine in question was on the agenda with the third dose recently.

now United States Food and Drug Administration (FDA) Advisory Board, with its decision, explained in which situations the third dose BioNTech vaccine should or should not be used. In this context, it was stated that the third dose will not be applied to everyone, but only to people who have a high probability of having a hard disease and to the elderly.

No third dose for 16 years and over:

FDA advisors voted 2 to 16 in their vote. 16 years and older third dose of vaccine refused. This is because there is not enough data available on how the third dose of vaccines will work in adults and how long it will last. But consultants 65 years and older third dose of vaccine for individuals Confirmed. In addition, a third dose of vaccine was deemed appropriate for individuals who are less resistant to the disease.

Last week, it was announced when the third dose of vaccines would be administered in our country. November December months were marked. again last week Health Minister Fahrettin Koca, said that the third dose of vaccine significantly increased the protection, the area covered by the total number of cases of people who received the third dose of vaccine not even 2 percent had stated. We will be keeping you informed of the developments about the vaccine.